Arvest Trust’s Novartis NVS Stock Holding History

Arvest Trust’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$2.64M	Sell	24,836 -1,664	-6%	-$167K	0.16%	71
2024 Q1	$2.56M	Sell	26,500 -1,001	-4%	-$103K	0.15%	76
2023 Q4	$2.78M	Buy	27,501 +177	+0.6%	+$17.1K	0.17%	70
2023 Q3	$2.78M	Sell	27,324 -250	-0.9%	-$25.4K	0.18%	68
2023 Q2	$2.89M	Sell	27,574 -1,665	-6%	-$167K	0.17%	71
2023 Q1	$2.69M	Buy	29,239 +6,234	+27%	+$544K	0.17%	72
2022 Q4	$2.09M	Buy	23,005 +3,801	+20%	+$320K	0.13%	77
2022 Q3	$1.46M	Buy	19,204 +3,206	+20%	+$266K	0.1%	87
2022 Q2	$1.35M	Buy	15,998 +2,702	+20%	+$237K	0.09%	82
2022 Q1	$1.17M	Buy	13,296 +1,920	+17%	+$166K	0.06%	88
2021 Q4	$995K	Buy	+11,376	New	+$945K	0.05%	94

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

CCM

Cullen Capital Management New York $9.75B AUM 21.81% 1-Year Est. Return

Arvest Trust's NVS Position: Q2 2024 in Review

Arvest Trust reduced its Novartis (NVS) stake by 6.3% in Q2 2024, selling an estimated $167K and leaving 24,836 shares worth $2.64M. The position accounts for 0.16% of the portfolio, ranked #71.

Arvest Trust first reported a position in NVS in Q4 2021 and has held it in 11 quarters since. The position peaked at $2.89M in Q2 2023. 1,307 funds tracked by Wall St. Rank hold NVS as of Q2 2024.

Arvest Trust held 24,836 shares of Novartis worth $2.64M as of Q2 2024.
Arvest Trust sold 1,664 Novartis shares in Q2 2024, an estimated $167K.
Novartis made up 0.16% of Arvest Trust's portfolio in Q2 2024, its #71 holding.
Arvest Trust first reported a position in Novartis in Q4 2021 and has held it in 11 quarters since.
Arvest Trust's Novartis position peaked at $2.89M in Q2 2023.
1,307 funds tracked by Wall St. Rank held Novartis as of Q2 2024.

Based on Arvest Trust's 13F filing for Q2 2024, filed 9 Aug 2024.